204 related articles for article (PubMed ID: 32966755)
1. Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights.
Smith JA; Harle A; Dockry R; Holt K; Russell P; Molassiotis A; Yorke J; Robinson R; Birrell MA; Belvisi MG; Blackhall F
Am J Respir Crit Care Med; 2021 Mar; 203(6):737-745. PubMed ID: 32966755
[No Abstract] [Full Text] [Related]
2. Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.
Noronha V; Bhattacharjee A; Patil VM; Joshi A; Menon N; Shah S; Kannan S; Mukadam SA; Maske K; Ishi S; Prabhash K
Chest; 2020 Jun; 157(6):1647-1655. PubMed ID: 31958446
[TBL] [Abstract][Full Text] [Related]
3. Emerging targets for cough therapies; NK1 receptor antagonists.
Badri H; Smith JA
Pulm Pharmacol Ther; 2019 Dec; 59():101853. PubMed ID: 31622673
[TBL] [Abstract][Full Text] [Related]
4. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
Belvisi MG; Birrell MA; Wortley MA; Maher SA; Satia I; Badri H; Holt K; Round P; McGarvey L; Ford J; Smith JA
Am J Respir Crit Care Med; 2017 Nov; 196(10):1255-1263. PubMed ID: 28650204
[TBL] [Abstract][Full Text] [Related]
5. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin-1 Receptor Inhibition and Cough.
Turner RD; Birring SS
Am J Respir Crit Care Med; 2021 Mar; 203(6):672-674. PubMed ID: 33108214
[No Abstract] [Full Text] [Related]
7. Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.
Wu F; Lin X; Yang Z; Sun Z; Zeng F; Heng J; Qu J; Zeng L; Yang N; Zhang Y
Clin Lung Cancer; 2018 Nov; 19(6):e913-e918. PubMed ID: 30197265
[TBL] [Abstract][Full Text] [Related]
8. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.
Yahata H; Kobayashi H; Sonoda K; Shimokawa M; Ohgami T; Saito T; Ogawa S; Sakai K; Ichinoe A; Ueoka Y; Hasuo Y; Nishida M; Masuda S; Kato K
Int J Clin Oncol; 2016 Jun; 21(3):491-7. PubMed ID: 26662632
[TBL] [Abstract][Full Text] [Related]
10. Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?
Muñoz M; Muñoz ME; Morell F; Coveñas R
Arch Bronconeumol; 2022 Oct; 58(10):727-728. PubMed ID: 35606264
[No Abstract] [Full Text] [Related]
11. N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough.
Louly PG; Medeiros-Souza P; Santos-Neto L
Clin Ther; 2009 May; 31(5):1007-13. PubMed ID: 19539101
[TBL] [Abstract][Full Text] [Related]
12. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
Khalid S; Murdoch R; Newlands A; Smart K; Kelsall A; Holt K; Dockry R; Woodcock A; Smith JA
J Allergy Clin Immunol; 2014 Jul; 134(1):56-62. PubMed ID: 24666696
[TBL] [Abstract][Full Text] [Related]
13. Theophylline inhibits the cough reflex through a novel mechanism of action.
Dubuis E; Wortley MA; Grace MS; Maher SA; Adcock JJ; Birrell MA; Belvisi MG
J Allergy Clin Immunol; 2014 Jun; 133(6):1588-98. PubMed ID: 24406072
[TBL] [Abstract][Full Text] [Related]
14. Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study.
Lavorini F; Spina D; Walker MJ; Franciosi L; Page CP; Fontana GA
Pulm Pharmacol Ther; 2016 Oct; 40():91-4. PubMed ID: 27538683
[TBL] [Abstract][Full Text] [Related]
15. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
Piechotta V; Adams A; Haque M; Scheckel B; Kreuzberger N; Monsef I; Jordan K; Kuhr K; Skoetz N
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012775. PubMed ID: 34784425
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the antitussive efficacy of codeine in cough associated with common cold.
Freestone C; Eccles R
J Pharm Pharmacol; 1997 Oct; 49(10):1045-9. PubMed ID: 9364418
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer.
Kusagaya H; Inui N; Karayama M; Fujisawa T; Enomoto N; Kuroishi S; Nakamura Y; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yamada T; Shirai T; Hayakawa H; Suda T
Lung Cancer; 2015 Dec; 90(3):410-6. PubMed ID: 26791800
[TBL] [Abstract][Full Text] [Related]
18. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.
Abdulqawi R; Dockry R; Holt K; Layton G; McCarthy BG; Ford AP; Smith JA
Lancet; 2015 Mar; 385(9974):1198-205. PubMed ID: 25467586
[TBL] [Abstract][Full Text] [Related]
19. Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients.
Moroni M; Porta C; Gualtieri G; Nastasi G; Tinelli C
Br J Cancer; 1996 Jul; 74(2):309-11. PubMed ID: 8688342
[TBL] [Abstract][Full Text] [Related]
20. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1).
Smith J; Allman D; Badri H; Miller R; Morris J; Satia I; Wood A; K Trower M
Chest; 2020 Jan; 157(1):111-118. PubMed ID: 31421110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
